KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $3.1 billion.

  • Gilead Sciences' Income from Continuing Operations rose 14357.54% to $3.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 billion, marking a year-over-year increase of 707699.12%. This contributed to the annual value of $479.0 million for FY2024, which is 9146.47% down from last year.
  • Gilead Sciences' Income from Continuing Operations amounted to $3.1 billion in Q3 2025, which was up 14357.54% from $2.0 billion recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Income from Continuing Operations ranged from a high of $3.1 billion in Q3 2025 and a low of -$4.2 billion during Q1 2024
  • In the last 5 years, Gilead Sciences' Income from Continuing Operations had a median value of $1.5 billion in 2021 and averaged $1.2 billion.
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first surged by 810000.0% in 2023, then plummeted by 52388.21% in 2024.
  • Over the past 5 years, Gilead Sciences' Income from Continuing Operations (Quarter) stood at $376.0 million in 2021, then soared by 334.31% to $1.6 billion in 2022, then dropped by 13.29% to $1.4 billion in 2023, then increased by 25.85% to $1.8 billion in 2024, then skyrocketed by 71.27% to $3.1 billion in 2025.
  • Its last three reported values are $3.1 billion in Q3 2025, $2.0 billion for Q2 2025, and $1.3 billion during Q1 2025.